Jack Arbiser, MD
Dermatology · Atlanta, GANPI 1710092648
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $6,510 of the $7,635 with a category attached, or 85.3%. Regeneron Healthcare Solutions, Inc. accounts for 88.6% of it on its own, with 12 other manufacturers making up the rest. Reporting peaked in 2020 at $6,510 and has fallen 96.5% since, to $231 in 2025.
Across 35 payments — averaging $218.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$7K
- Sanofi$264
- Johnson & Johnson$215
- Arcutis Biotherapeutics, Inc.$135
- Incyte Corporation$57
- Pfizer$39
- plus $162 from 7 others
Across 24 payments — averaging $18,572 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Regeneron$430K
- Amgen$16K
What the payments were for
- Consulting fees$6,51085%
- Food & beverage$1,04414%
- Education$801%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $6,763 |
| Sanofi | 9 | $264 |
| Johnson & Johnson | 3 | $215 |
| Arcutis Biotherapeutics, Inc. | 6 | $135 |
| Incyte Corporation | 3 | $57 |
| Pfizer | 2 | $39 |
| Novartis | 1 | $31 |
| Verrica Pharmaceuticals Inc. | 1 | $30 |
| Krystal Biotech Inc | 1 | $28 |
| Amgen | 1 | $24 |
| Sun Pharmaceutical Industries Inc. | 1 | $17 |
| Galderma Laboratories, L.p. | 1 | $17 |
| Mayne Pharma Commercial LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,635 in reported general payments places this provider in the 65th percentile of 345 dermatology providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 127 | $6,514 |
| Ammonium Lactate | 145 | $2,681 |
| CiclopiroxCiclopirox Olamine | 90 | $1,706 |
| Metronidazole | 20 | $1,574 |
| Triamcinolone Acetonide | 101 | $1,515 |
| Tretinoin | 14 | $1,496 |
| Montelukast Sodium | 143 | $712 |
| Ketoconazole | 45 | $494 |
| Ciclopirox | 11 | $444 |
| Minoxidil | 21 | $402 |
| Doxycycline Hyclate | 20 | $395 |
| Doxepin Hcl | 20 | $291 |
| Imiquimod | 12 | $242 |
| Mupirocin | 36 | $180 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Atlanta
- Zakiya RiceAtlanta$1.1M
- Joseph PayneAtlanta$711K
- Jamie WeismanAtlanta$620K
- Mack RachalAtlanta$260K
- Sumayah TaliaferroAtlanta$104K
- Sarah ChisolmAtlanta$59K
- Anna PareAtlanta$58K
- Lauren OrensteinAtlanta$52K
- Chelsie RogersAtlanta$43K
- Ron FeldmanAtlanta$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.